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Abstract
Keloid formation is one of the most challenging clinical problems in wound healing. With increasing frequency of
open heart surgery, chest keloid formations are not infrequent in the clinical practice. The numerous treatment
methods including surgical excision, intralesional steroid injection, radiation therapy, laser therapy, silicone gel
sheeting, and pressure therapy underscore how little is understood about keloids. Keloids have a tendency to recur
after surgical excision as a single treatment. Stretching tension is clearly associated with keloid generation, as
keloids tend to occur on high tension sites such as chest region. The authors treated 58 chest keloid patients with
surgical excision followed by intraoperative and postoperative intralesional steroid injection. Even with minor
complications and recurrences, our protocol results in excellent outcomes in cases of chest keloids.
Background
Keloids are relatively resistant to treatment, with high
recurrence rates using a single treatment modality.
Keloids have a tendency to recur after surgical excision
as a single treatment, with rates approximately up to
80-100%. Keloids can arise from skin trauma and must
be removed through skin truma. Therein lies the chal-
lenge of treatment, where recurrence would seem inevi-
table. Surgical excision is considered as a kind of skin
trauma and it promotes additional collagen synthesis,
resulting in regrowth and even larger keloids [1]. This is
why we were focused on the article recently published
in your esteemed journal by Patel et al. [2] that dealt
with the challenging topic of chest keloids.
Patients and Methods
58 patients were treated with surgical excision combined
with intraoperative/postoperative intralesional steroid
injection therapy over a period of six years from July
2003 to June 2009 at our hospital. In all patients, a fol-
low-up period of 18 months was required. Treatment
outcome was assessed with global aesthetic improve-
ment score (GAIS). All statistical analyses were con-
ducted using SPSS version 17.0 (SPSS, Inc., Chicago, IL,
USA). Our data were not normally distributed; conse-
quently non-parametric tests were used. Descriptive sta-
tistics are presented as medians with interquartile
ranges or as numbers and percentages.
Results
41 (70.7%) were women and 17 (29.3%) were men. The
average age was 32 (range 29-35). The average time
interval between keloid formation (or prior complete
treatment) and time of treatment was 6 (range 5-7)
years. The average pretreatment total size of lesions was
3.5 (range 2.0-5.0). 45 patients (29.3%) were treated for
a treatment-resistant keloid that failed to respond to
previous interventions. These included surgical excision
(2 patients, 3.4%), intralesional steroid injection
(33 patients, 56.9%), laser therapy (5 patients, 8.6%),
acupuncture (3 patients, 5.3%), and cryotherapy
(2 patients, 3.4%). The etiologies of chest keloid, in
order of decreasing frequency, were the acne scar
(20 patients, 34.5%, Figure 1), cardiothoracic surgery
(12 patients, 20.7%; Figure 2), burn scar (10 patients,
17.2%; Figure 3), infection (10 patients, 17.2%) and
trauma (6 patients, 10.4%; Figure 4). (Table 1)
Discussion
Although various surgical techniques are introduced in
the medical literature, surgical excision alone is inade-
quate considering high recurrence rate of keloids [3].
In the cases of chest keloids, our treatment protocol was
surgical excision with intraoperative and postoperative
intralesional steroid injections. Patients were informed
of the possible keloid recurrence and were told to return
if a scar was reelevated or extended beyond the demen-
sions of the initial lesion. Even with minor complaints,
such as pruritus, pain, tenderness, and secondary infec-
tion, most patients were satisfied with the outcomes.
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any medium, provided the original work is properly cited.Diverse adjuvant methods after surgical excision includ-
ing intralesional corticosteroids injection, pressure ther-
apy, radiation therapy, topical silicone-gel sheeting,
cryotherapy, and laser treatment have been proposed for
keloids. In the chest keloids, radiation therapy cannot be
the primary adjuvant therapy because of its possible risk
of radiation-induced malignancy. Thyroid and breast car-
cinoma after radiation therapy for keloids have been
reported in the medical literatures [4]. In addition, var-
ious pressure devices cannot be properly applied on the
chest region [5,6]. Even though silicone gel is comfortable
and sometimes useful, it requires active patient compli-
ance and long-term application can be challenging [7].
We also stress adequate follow-up periods are manda-
tory to properly assess the outcome of treatment proto-
col. According to available literatures, at least
12 months follow period is recommended.
Conclusions
Although the exact pathogenesis of keloid remains
unclear, stretching tension is clearly associated with
keloid generation, as keloids tend to occur on high ten-
sion sites such as chest region. Therefore, it is difficult
to completely eradicate keloids from this region. Even
with minor complications and recurrences, we think
surgical excision with intraoperative and postoperative
intralesional steroid injection remains the treatment of
choice in the chest keloids.
Informed consent
Written informed consent was obtained from the patient
for publication of this article and accompanying images.
A copy of the written consent is available for review by
the Editor-in-Chief of this journal.
Figure 1 Chest keloid after acne scar.
Figure 2 Chest keloid after open heart surgery.
Figure 3 Chest keloid after severe burn injury.
Figure 4 Chest keloid after shell splinters injury.
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Table 1 Baseline Patient Characteristics
Total Patients (n = 58)
Age, years 32.00 (29.00-35.00)
Total size, cm 3.50 (2.00-5.00)
Age of keloids, years 6.00 (5.00-7.00)
BMI, kg/m
2 23.00 (21.00-25.00)
Gender:
Female, n (%) 41 (70.7%)
Male, n (%) 17 (29.3%)
Previous treatment history:
No, n (%) 13 (22.4%)
Yes, n (%) 45 (77.6%)
Surgical excision, n (%) 2 (3.4%)
Steroid injection, n (%) 33 (56.9%)
Laser therapy, n (%) 5 (8.6%)
Acupuncture, n (%) 3 (5.3%)
cryotherapy, n (%) 2 (3.4%)
Etiology:
Acne scar, n (%) 20 (34.5%)
Cardiothoracic surgery, n (%) 12 (20.7%)
Burn scar, n (%) 10 (17.2%)
Infection, n (%) 10 (17.2%)
Idiopathic, n (%) 6 (10.4%)
Values are median(IQR) for continuous variables and number (percentages) for
categorical variables.
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